Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

TRAF6 and Src kinase activity regulates Cot activation by IL-1.

Cristina Rodríguez1, Maite Pozo, Elvira Nieto

  • 1Instituto de Investigaciones Biomédicas, CSIC, Facultad de Medicina, UAM, Arturo Duperier 4, 28029 Madrid, Spain.

Cellular Signalling
|December 24, 2005
PubMed
Summary

Interleukin-1 (IL-1) activates the ERK1/ERK2 pathway via Cot kinase, a MAP kinase kinase kinase. This pathway is crucial for IL-1-induced gene expression, highlighting Cot

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early real-world effectiveness of mirikizumab in a difficult-to-treat ulcerative colitis cohort.

Gastroenterologia y hepatologia·2026
Same author

Clinical Outcomes and Predictors of Adverse Events in Influenza Patients Managed in a Hospital-at-Home Program: A 10-Year Retrospective Study.

American journal of medicine open·2026
Same author

Transcriptional states define dependencies and therapeutic vulnerabilities in head and neck cancer.

NPJ precision oncology·2026
Same author

Perivascular adipose tissue modulates aortic reactivity in Marfan syndrome mice in a sex- and region-specific manner: Redox-dependent anticontractile effects in the female ascending aorta.

Biochemical pharmacology·2026
Same author

Assessing the role of community pharmacists in early skin cancer detection: a real-world study.

Scientific reports·2026
Same author

Understanding the Impact of Hypoxia on Pulmonary Artery Endothelial Cells in Chronic Thromboembolic Pulmonary Hypertension Patients.

International journal of molecular sciences·2026

Area of Science:

  • Cellular signaling pathways
  • Immunology
  • Molecular biology

Background:

  • Cot is a MAP kinase kinase kinase regulating the ERK1/ERK2 pathway.
  • Cot activation by lipopolysaccharide (LPS) involves dissociation from NF-kappaB in macrophages.
  • Interleukin-1 (IL-1) is a key cytokine in inflammatory responses.

Purpose of the Study:

  • To investigate the role of Cot in IL-1-mediated signaling.
  • To identify the specific MAP kinase kinase kinase activated by IL-1.
  • To elucidate the downstream effects of IL-1-induced Cot activation on gene expression.

Main Methods:

  • Measurement of endogenous Cot activity in response to IL-1.
  • Analysis of IL-1-induced gene expression (IL-8, MIP-1beta) in cells with blocked Cot expression.

Related Experiment Videos

  • Investigation of the involvement of TRAF6 and Src tyrosine kinases in IL-1 signaling.
  • Use of PP1 inhibitor to assess the role of Src kinases.

    • Main Results:

    • IL-1 induces a 10-fold increase in Cot activity, uniquely activating the ERK1/ERK2 pathway.
    • Blocking Cot expression prevents IL-1-induced upregulation of IL-8 and MIP-1beta mRNA.
    • IL-1-induced activation of the Cot-MKK1-ERK1/ERK2 pathway requires TRAF6.
    • IL-1-mediated ERK1/ERK2 activation is inhibited by PP1, implicating Src tyrosine kinases, but not p38 or JNK activation.
    • Src kinase inhibition does not affect IL-1-induced Cot dissociation, suggesting additional activation steps.

    Conclusions:

    • Cot is the sole MAP kinase kinase kinase responsible for IL-1-induced ERK1/ERK2 activation.
    • The Cot-MKK1-ERK1/ERK2 pathway is essential for IL-1-mediated induction of specific inflammatory genes.
    • IL-1 signaling to ERK1/ERK2 involves TRAF6 and Src tyrosine kinases, with post-dissociation events critical for Cot activation.